Clinical Trial: Ofatumumab
MS study to evaluate the effectiveness of ofatumumab after transitioning from oral therapy, in adults 18 to 60 with relapsing MS experiencing breakthrough disease. Study participation includes in-person visits, blood draws, MRI appointments, and use of electronic devices and ...
Get Details